241 related articles for article (PubMed ID: 7039419)
1. Dantrolene in human malignant hyperthermia.
Kolb ME; Horne ML; Martz R
Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419
[TBL] [Abstract][Full Text] [Related]
2. Malignant hyperthermia with excellent response to small dose of dantrolene.
Chang KY; Ting CK; Chan KH; Tsai SK
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
[TBL] [Abstract][Full Text] [Related]
3. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
Flewellen EH; Nelson TE
Anesthesiology; 1980 Apr; 52(4):303-8. PubMed ID: 7362049
[TBL] [Abstract][Full Text] [Related]
4. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
Brandom BW; Larach MG; Chen MS; Young MC
Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
[TBL] [Abstract][Full Text] [Related]
6. Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
Larach MG; Klumpner TT; Brandom BW; Vaughn MT; Belani KG; Herlich A; Kim TW; Limoncelli J; Riazi S; Sivak EL; Capacchione J; Mashman D; Kheterpal S; Kooij F; Wilczak J; Soto R; Berris J; Price Z; Lins S; Coles P; Harris JM; Cummings KC; Berman MF; Nanamori M; Adelman BT; Wedeven C; LaGorio J; McCormick PJ; Tom S; Aziz MF; Coffman T; Ellis TA; Molina S; Peterson W; Mackey SC; van Klei WA; Ginde AA; Biggs DA; Neuman MD; Craft RM; Pace NL; Paganelli WC; Durieux ME; Nair BJ; Wanderer JP; Miller SA; Helsten DL; Turnbull ZA; Schonberger RB;
Anesthesiology; 2019 Jan; 130(1):41-54. PubMed ID: 30550426
[TBL] [Abstract][Full Text] [Related]
7. Do we foresee new emerging drugs to treat malignant hyperthermia?
Just KS; Gerbershagen MU; Grensemann J; Wappler F
Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
[TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia: clinical course and metabolic changes in two patients.
Rutberg H; Håkanson E
Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577
[TBL] [Abstract][Full Text] [Related]
9. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
Harrison GG
S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
[TBL] [Abstract][Full Text] [Related]
10. Donating Dantrolene: Development and Implementation of a Malignant Hyperthermia Program in a Scarce Resource Setting.
Smith A; Brandom B; Miner L; Henker R
AANA J; 2022 Aug; 90(4):271-277. PubMed ID: 35943752
[TBL] [Abstract][Full Text] [Related]
11. Postoperative malignant hyperthermia and dantrolene therapy.
Schulte-Sasse U; Hess W; Eberlein HJ
Can Anaesth Soc J; 1983 Nov; 30(6):635-40. PubMed ID: 6640400
[TBL] [Abstract][Full Text] [Related]
12. Dantrolene in porcine malignant hyperthermia.
Gronert GA; Milde JH; Theye RA
Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
Schuster F; Johannsen S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
[TBL] [Abstract][Full Text] [Related]
14. A survey for prevention and treatment of malignant hyperthermia in Taiwan.
Yip WH; Mingi CL; Ooi SJ; Chen SC; Chiang YY
Acta Anaesthesiol Taiwan; 2004 Sep; 42(3):147-51. PubMed ID: 15551892
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
Schleelein LE; Litman RS
Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974
[TBL] [Abstract][Full Text] [Related]
16. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
Alitalo I; Schulman A
Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
[TBL] [Abstract][Full Text] [Related]
17. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
[TBL] [Abstract][Full Text] [Related]
18. [Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction].
Schulte-Sasse U; Eberlein HJ
Anaesthesiol Reanim; 1991; 16(3):202-7. PubMed ID: 1888426
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
Blank JW; Boggs SD
J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
[TBL] [Abstract][Full Text] [Related]
20. Effect of dantrolene on leg metabolism in porcine malignant hyperthermia.
Hall GM; Lucke JN; Orchard C; Lovell R; Lister D
Anaesthesia; 1982 Dec; 37(12):1167-70. PubMed ID: 7181063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
